×
About 2,963 results

ALLMedicine™ Ovarian Insufficiency Center

Research & Reviews  1,443 results

Prevalence and clinical associations with premature ovarian insufficiency, early menopa...
https://doi.org/10.1007/s10067-020-05522-5
Clinical Rheumatology; Jutiviboonsuk A, Salang L et. al.

Nov 27th, 2020 - The low prevalence of pregnancy in women with systemic sclerosis (SSc) is due to multi-factorial causes, including premature ovarian insufficiency (POI). The study aimed to determine the prevalence of POI, early menopausal status, and any clinical...

Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680585
Journal of Ovarian Research; Cai X, Fu H et. al.

Nov 22nd, 2020 - Genetic causes of premature ovarian insufficiency (POI) account for approximately 20 ~ 25% of patients. So far, only a few genes have been identified. Here, we first identified the c.1840C > A on G-protein signaling modulator 1 (GPSM1) as a suscep...

Knowledge of iatrogenic premature ovarian insufficiency among Chinese obstetricians and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677772
Journal of Ovarian Research; Wang Y, Zou Y et. al.

Nov 19th, 2020 - With increasing cases of iatrogenic premature ovarian insufficiency (POI), more clinicians are required to counsel patients regarding the gonadotoxic effects of iatrogenic treatments. This survey aimed to explore obstetricians and gynaecologists' ...

The effect of selenium and vitamin E supplementation on anti-Mullerian hormone and antr...
https://doi.org/10.1016/j.ctim.2020.102533
Complementary Therapies in Medicine; Safiyeh FD, Mojgan M et. al.

Nov 16th, 2020 - Increased accumulation of reactive oxygen species (ROS) in the process of oogenesis is one of the most well known causes of ovarian insufficiency and decreased ovarian reserve. Selenium and vitamin E as cofactors of glutathione peroxidase plays an...

Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathwa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684879
Molecular Medicine Reports; He L, Wang X et. al.

Nov 12th, 2020 - The aim of the present study was to investigate the effects of the ginsenoside Rg1 on D‑galactose (D‑gal)‑induced mouse models of premature ovarian insufficiency (POI) and the related mechanisms. C57BL/6 female mice were randomly grouped into the ...

see more →

Guidelines  7 results

Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency.
https://doi.org/10.1097/AOG.0000000000002044
Obstetrics and Gynecology;

Apr 20th, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...

Committee Opinion No. 698 Summary: Hormone Therapy in Primary Ovarian Insufficiency.
https://doi.org/10.1097/AOG.0000000000002040
Obstetrics and Gynecology;

Apr 20th, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...

The British Menopause Society and Women's Health Concern recommendations on the managem...
https://doi.org/10.1177/2053369117699358
Post Reproductive Health; Hamoda H,

Apr 6th, 2017 - The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.|2017|Hamoda H, ,|epidemiology,etiology,adverse effects,methods,etiology,complications,drug therapy,etiology,p...

ESHRE Guideline: management of women with premature ovarian insufficiency.
https://doi.org/10.1093/humrep/dew027
Human Reproduction (Oxford, England); , Webber L et. al.

Mar 24th, 2016 - What is the optimal management of women with premature ovarian insufficiency (POI) based on the best available evidence in the literature? The guideline development group (GDG) formulated 99 recommendations answering 31 key questions on the diagno...

ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific...
https://doi.org/10.1038/gim.2013.61
Genetics in Medicine : Official Journal of the American College of Medical Genetics; Monaghan KG, Lyon E et. al.

Jun 14th, 2013 - Molecular genetic testing of the FMR1 gene is commonly performed in clinical laboratories. Mutations in the FMR1 gene are associated with fragile X syndrome, fragile X tremor ataxia syndrome, and premature ovarian insufficiency. This document prov...

see more →

Clinicaltrials.gov  1,483 results

Prevalence and clinical associations with premature ovarian insufficiency, early menopa...
https://doi.org/10.1007/s10067-020-05522-5
Clinical Rheumatology; Jutiviboonsuk A, Salang L et. al.

Nov 27th, 2020 - The low prevalence of pregnancy in women with systemic sclerosis (SSc) is due to multi-factorial causes, including premature ovarian insufficiency (POI). The study aimed to determine the prevalence of POI, early menopausal status, and any clinical...

Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680585
Journal of Ovarian Research; Cai X, Fu H et. al.

Nov 22nd, 2020 - Genetic causes of premature ovarian insufficiency (POI) account for approximately 20 ~ 25% of patients. So far, only a few genes have been identified. Here, we first identified the c.1840C > A on G-protein signaling modulator 1 (GPSM1) as a suscep...

Knowledge of iatrogenic premature ovarian insufficiency among Chinese obstetricians and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677772
Journal of Ovarian Research; Wang Y, Zou Y et. al.

Nov 19th, 2020 - With increasing cases of iatrogenic premature ovarian insufficiency (POI), more clinicians are required to counsel patients regarding the gonadotoxic effects of iatrogenic treatments. This survey aimed to explore obstetricians and gynaecologists' ...

The effect of selenium and vitamin E supplementation on anti-Mullerian hormone and antr...
https://doi.org/10.1016/j.ctim.2020.102533
Complementary Therapies in Medicine; Safiyeh FD, Mojgan M et. al.

Nov 16th, 2020 - Increased accumulation of reactive oxygen species (ROS) in the process of oogenesis is one of the most well known causes of ovarian insufficiency and decreased ovarian reserve. Selenium and vitamin E as cofactors of glutathione peroxidase plays an...

Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathwa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684879
Molecular Medicine Reports; He L, Wang X et. al.

Nov 12th, 2020 - The aim of the present study was to investigate the effects of the ginsenoside Rg1 on D‑galactose (D‑gal)‑induced mouse models of premature ovarian insufficiency (POI) and the related mechanisms. C57BL/6 female mice were randomly grouped into the ...

see more →

News  17 results

UK Guidelines Quiz – Menopause: Diagnosis and Management
https://www.medscape.com/viewarticle/919637

Oct 17th, 2019 - In the reviewed guideline: ‘Menopause: diagnosis and management’ the National Institute for Health and Care Excellence (NICE) aims to improve the consistency of support and information provided to women in menopause. It includes guidance for the d...

No increase in primary ovarian insufficiency with HPV vaccine
https://www.mdedge.com/obgyn/article/172987/vaccines/no-increase-primary-ovarian-insufficiency-hpv-vaccine
Bianca Nogrady

Aug 21st, 2018 - The human papillomavirus vaccine does not appear to be associated with an increased risk of ovarian insufficiency, according to researchers. Choreograph/Thinkstock Allison L.

VIDEO: Dr. Matteo Lambertini answers questions on temporary ovarian suppression
https://www.mdedge.com/obgyn/article/153819/breast-cancer/video-dr-matteo-lambertini-answers-questions-temporary-ovarian
Susan London

Dec 7th, 2017 - SAN ANTONIO – A meta-analysis of five trials among 873 premenopausal women with early breast cancer finds that temporarily suppressing ovarian function with a gonadotropin-releasing hormone analog during chemotherapy helps preserve fertility, redu.

ESHRE writes first premature ovarian insufficiency guidelines
https://www.mdedge.com/internalmedicine/article/86417/gynecology/eshre-writes-first-premature-ovarian-insufficiency
Mitchel L. Zoler

Aug 12th, 2014 - MUNICH – A working group of the European Society of Human Reproduction and Embryology drafted the first international guidelines for managing premature ovarian insufficiency. Once formally released, by late this year or soon after, the guidelines.

Procedure Beats Ovarian Deficit, Baby Born
https://www.medpagetoday.com/obgyn/pregnancy/41979

Sep 30th, 2013 - Action Points The investigators demonstrated that fragmentation of murine ovaries and disruption of ovarian Hippo signaling led to promotion of follicle growth and the generation of oocytes. They were able to show that using these procedures for t...

see more →

Patient Education  13 results see all →